Since glycerol is a key metabolite for lipid accumulation in fat depots and liver, the improvement of glycerol availability might be involved in the beneficial effects of leptin on obesity and NAFLD. Here, LEP is linked to metabolic dysfunction-associated steatotic liver disease.